Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

<jats:sec id="S0033291714000014_sec_a1"><jats:title>Background</jats:title><jats:p>Oxidative stress and neurotrophic factors have been implicated in the pathophysiology of bipolar disorder. Our objective was to determine whether plasma glutathione or brain-derived neurotrophic factor (BDNF) levels were abnormal in bipolar disorder and therefore useful as possible biomarkers.</jats:p></jats:sec><jats:sec id="S0033291714000014_sec_a2" sec-type="methods"><jats:title>Method</jats:title><jats:p>Blood samples were collected from subsyndromal, medicated bipolar I patients (<jats:italic>n</jats:italic> = 50), recruited from OXTEXT, University of Oxford, and from 50 matched healthy controls. Total and oxidized glutathione levels were measured using an enzymatic recycling method and used to calculate reduced, percentage oxidized, ratio of reduced:oxidized and redox state. BDNF was measured using an enzyme-linked immunoassay. Self-monitored mood scores for the bipolar group were available (Quick Inventory of Depressive Symptomatology and the Altman Self-Rating Mania Scale) over an 8-week period.</jats:p></jats:sec><jats:sec id="S0033291714000014_sec_a3" sec-type="results"><jats:title>Results</jats:title><jats:p>Compared with controls, bipolar patients had significantly lower levels of total glutathione and it was more oxidized. BDNF levels were not different. Age of illness onset but not current mood state correlated with total glutathione levels and its oxidation status, so that lower levels of total and reduced glutathione were associated with later onset of disease, not length of illness.</jats:p></jats:sec><jats:sec id="S0033291714000014_sec_a4" sec-type="conclusion"><jats:title>Conclusions</jats:title><jats:p>Plasma glutathione levels and redox state detect oxidative stress even in subsyndromal patients with normal BDNF. It may relate to the onset and development of bipolar disorder. Plasma glutathione appears to be a suitable biomarker for detecting underlying oxidative stress and for evaluating the efficacy of antioxidant intervention studies.</jats:p></jats:sec>

Original publication

DOI

10.1017/s0033291714000014

Type

Journal article

Journal

Psychological Medicine

Publisher

Cambridge University Press (CUP)

Publication Date

08/2014

Volume

44

Pages

2409 - 2418